로딩 중…
지수 로딩 중…
BioCryst Pharmaceuticals, Inc.
BCRX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$8.81-1.89%
2026-08-03
Financials
Valuation Metrics
BioCryst Pharmaceuticals, Inc.'s Market Cap is $2.24B. At end of 2025 it was $1.65B. Ranked #1975 of 3,112 in US market (top 63%), #744 of 1,445 on NASDAQ (top 51%), #125 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 46%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.24B | US#1,975/3,112 Sec#125/269 |
| Revenue | $886M | US#2,003/3,112 Sec#58/269 |
| Net Income | $-458M | US—/3,112 Sec—/269 |
| Total Assets | $465M | US#2,772/3,112 Sec#165/269 |
| Net Assets | $-554M | US#3,035/3,112 Sec#269/269 |
| Value | ||
| P/S | 2.53x | US#1,532/3,112 Sec#42/269 |
| FCF Yield | 13.13% | US#301/3,112 Sec#12/269 |
| Profitability | ||
| ROA | -98.48% | US#3,045/3,112 Sec#264/269 |
| Op. Margin | -43.11% | US#2,763/3,112 Sec#113/269 |
| Revenue Growth | 7.48% | US#1,496/3,112 Sec#100/269 |
| Earnings Growth | -2255762.50% | US#2,405/3,112 Sec#96/269 |
| Financial Health | ||
| Total Debt | $858M | US#1,559/3,112 Sec#46/269 |
| FCF | $294M | US#1,146/3,112 Sec#37/269 |
| Cash | $172M | US#1,832/3,112 Sec#130/269 |
| Current Ratio | 1.91x | US#1,306/3,112 Sec#232/269 |
| Performance | ||
| 1Y Return | 10.82% | US#2,047/3,112 Sec#191/269 |
| 1M Return | -10.47% | US#2,621/3,112 Sec#168/269 |
| From 52W High | -21.48% | US#1,786/3,112 Sec#116/269 |
| 1Y MDD | -44.24% | US#2,172/3,112 Sec#164/269 |
| Trading | ||
| Volume | 3,079,984 shares | US#611/3,112 Sec#53/269 |
| Trading Value | $27M | US#1,787/3,112 Sec#126/269 |
| Per Share | ||
| EPS | $1.25 | US#1,528/3,112 Sec#52/269 |